BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3511049)

  • 1. The major excreted protein of transformed fibroblasts is an activable acid-protease.
    Gal S; Gottesman MM
    J Biol Chem; 1986 Feb; 261(4):1760-5. PubMed ID: 3511049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism for selective secretion of a lysosomal protease by transformed mouse fibroblasts.
    Dong JM; Prence EM; Sahagian GG
    J Biol Chem; 1989 May; 264(13):7377-83. PubMed ID: 2540189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and expression of the gene for the major excreted protein of transformed mouse fibroblasts. A secreted lysosomal protease regulated by transformation.
    Troen BR; Ascherman D; Atlas D; Gottesman MM
    J Biol Chem; 1988 Jan; 263(1):254-61. PubMed ID: 2826441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basis for low affinity binding of a lysosomal cysteine protease to the cation-independent mannose 6-phosphate receptor.
    Dong JM; Sahagian GG
    J Biol Chem; 1990 Mar; 265(8):4210-7. PubMed ID: 2155213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cathepsin L synthesized by normal and transformed cells at the gene, message, protein, and oligosaccharide levels.
    Stearns NA; Dong JM; Pan JX; Brenner DA; Sahagian GG
    Arch Biochem Biophys; 1990 Dec; 283(2):447-57. PubMed ID: 2275556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The major excreted protein (MEP) of transformed mouse cells and cathepsin L have similar protease specificity.
    Gal S; Gottesman MM
    Biochem Biophys Res Commun; 1986 Aug; 139(1):156-62. PubMed ID: 3533059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a cloned multidrug resistance gene for coamplification and overproduction of major excreted protein, a transformation-regulated secreted acid protease.
    Kane SE; Troen BR; Gal S; Ueda K; Pastan I; Gottesman MM
    Mol Cell Biol; 1988 Aug; 8(8):3316-21. PubMed ID: 2463474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of the major excreted protein (MEP) from a transformed mouse fibroblast cell line as a catalytically active precursor form of cathepsin L.
    Mason RW; Gal S; Gottesman MM
    Biochem J; 1987 Dec; 248(2):449-54. PubMed ID: 3435459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor.
    Mason RW; Wilcox D; Wikstrom P; Shaw EN
    Biochem J; 1989 Jan; 257(1):125-9. PubMed ID: 2537618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
    Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
    Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predominant secreted protein of transformed murine fibroblasts carries the lysosomal mannose 6-phosphate recognition marker.
    Sahagian GG; Gottesman MM
    J Biol Chem; 1982 Sep; 257(18):11145-50. PubMed ID: 6286683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the transport of a lysosomal enzyme by PDGF.
    Prence EM; Dong JM; Sahagian GG
    J Cell Biol; 1990 Feb; 110(2):319-26. PubMed ID: 2153682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cathepsin L in malignant transformation.
    Kane SE; Gottesman MM
    Semin Cancer Biol; 1990 Apr; 1(2):127-36. PubMed ID: 2103489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose regulates protein catabolism in ras-transformed fibroblasts through a lysosomal-dependent proteolytic pathway.
    Tournu C; Obled A; Roux MP; Ferrara M; Omura S; Béchet DM
    Biochem J; 2001 Jul; 357(Pt 1):255-61. PubMed ID: 11415457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-hydroxy-3-methylglutaryl coenzyme A reductase is sterol-dependently cleaved by cathepsin L-type cysteine protease in the isolated endoplasmic reticulum.
    Moriyama T; Wada M; Urade R; Kito M; Katunuma N; Ogawa T; Simoni RD
    Arch Biochem Biophys; 2001 Feb; 386(2):205-12. PubMed ID: 11368343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in targeting and secretion of cathepsins B and L by BALB/3T3 fibroblasts and Moloney murine sarcoma virus-transformed BALB/3T3 fibroblasts.
    Achkar C; Gong QM; Frankfater A; Bajkowski AS
    J Biol Chem; 1990 Aug; 265(23):13650-4. PubMed ID: 2166039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cathepsins L and B and their endogenous inhibitors in embryonal fibroblasts transformed by different genes].
    Dilakian EA; Vinokurova SV; Zhurbitskaia VA; Komissarova EV; Topol' LZ; Kiselev FL; Solov'eva NI
    Vopr Med Khim; 1998; 44(1):35-42. PubMed ID: 9575611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downstream sequences mediate induction of the mouse cathepsin L promoter by phorbol esters.
    Troen BR; Chauhan SS; Ray D; Gottesman MM
    Cell Growth Differ; 1991 Jan; 2(1):23-31. PubMed ID: 1848774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization to the lysosomal cell death pathway upon immortalization and transformation.
    Fehrenbacher N; Gyrd-Hansen M; Poulsen B; Felbor U; Kallunki T; Boes M; Weber E; Leist M; Jäättelä M
    Cancer Res; 2004 Aug; 64(15):5301-10. PubMed ID: 15289336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between the regulation of DNA synthesis and the production of two secreted glycoproteins by 12-O-tetradecanoylphorbol-13-acetate in 3T3 cells and in phorbol ester nonresponsive 3T3 variants.
    Fienup VK; Jeng MH; Hamilton RT; Nilsen-Hamilton M
    J Cell Physiol; 1986 Nov; 129(2):151-8. PubMed ID: 3095338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.